RedHill Biopharma (RDHL) EBIT Margin (QoQ) (2012 - 2023)
RedHill Biopharma (RDHL) EBIT Margin (QoQ) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | RedHill Biopharma | 640,064.98 | 640,064.98 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 380,088.00 |
| Mar 31, 2023 | -21,619.00 |
| Dec 31, 2022 | -63,231.00 |
| Sep 30, 2022 | -943.00 |
| Jun 30, 2022 | -7,698.00 |
| Mar 31, 2022 | 76,833.00 |
| Dec 31, 2021 | -72,195.00 |
| Sep 30, 2021 | -3,523.00 |
| Jun 30, 2021 | 2,751.00 |
| Mar 31, 2021 | -361.00 |
| Dec 31, 2020 | 2,279.00 |
| Sep 30, 2020 | 923.00 |
| Jun 30, 2020 | -155,155.00 |
| Mar 31, 2020 | 87,149.00 |
| Dec 31, 2019 | 3,723.00 |
| Sep 30, 2019 | -8,943.00 |
| Jun 30, 2019 | 26,167.00 |
| Mar 31, 2019 | -20,860.00 |
| Dec 31, 2018 | 29,766.00 |
| Sep 30, 2018 | 3,466.00 |